Opinion

Video

Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

Author(s):

Sara M. Tolaney, MD, MPH

Patients on HER2-targeted therapies for HER2-positive metastatic breast cancer should be vigilant about potential side effects like heart toxicities and interstitial lung disease and should undergo regular heart function monitoring and lung scans to catch these side effects early.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Related Content
Image of woman.
July 18th 2025

What Makes a Quality Cancer Support Group?

Sue McCarthy
After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer: © stock.adobe.com.
July 15th 2025

Bria-IMT Improves Survival in Patients With Metastatic Breast Cancer

Spencer Feldman
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of women.
July 10th 2025

Diagnosis Day: What I Felt, What I Learned

Patti McGee
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
Breast cancer care differs around the world, revealing urgent unmet needs: © stock.adobe.com.
July 9th 2025

Layers of Pain: Decoding the Multifaceted Toxicity of Breast Cancer

Dr. Dinesh Raj Neupane
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.